EMBARGOED FOR RELEASE UNTIL 11 A.M. ET, WEDNESDAY, NOV. 11, 2020
PITTSBURGH, Nov. 11, 2020 – Researchers from the Pittsburgh Center for Pain Research at the University of Pittsburgh School of Medicine announced today in the journal Neuron that they’ve uncovered additional complexities behind mechanical allodynia–the sensation of pain from innocuous stimuli, such as light touch.
Different types of injury that cause mechanical allodynia activate distinct spinal circuits that process the information from the skin to the brain, scientists discovered. The finding may explain why pain medications don’t alleviate an adverse sensation in all patients. It also suggests that new treatment strategies for pain management need to consider ways in which pain signals are processed in the spinal cord.
“Even though the pain outcome is the same, the neural circuits that conduct the signal are different depending on the kind of injury you have–say, arthritis or nerve trauma,” said senior author Rebecca Seal, Ph.D., associate professor in Pitt’s Department of Neurobiology. “And if you have different neural pathways depending on the type of injury, that might explain why therapies sometimes don’t work.”
For patients who experience mechanical allodynia, even the most mundane actions can hurt: Putting on clothes or even tossing in bed can be excruciatingly painful. The condition currently has no cure.
While recent studies identified the critical role of skin receptors for the perception of pain after a light touch, little was known about the way information is transferred from the nerve endings in the skin to the central nervous system where the pain sensation forms.
“People typically think of mechanical allodynia as a condition that is uniform in terms of its underlying neural circuitry in the central nervous system,” said Seal. “We now show that is not the case.”
Pitt researchers used several pain models to determine if calretinin-expressing (CR) neurons located in the outermost layer of the dorsal horn–one of the three gray columns of the spinal cord–are important to convey mechanical allodynia.
Experiments in mice showed that these neurons are critical for transmitting pain signals induced by inflammatory injuries but not by nerve injury.
Conversely, another subset of neurons of the spinal cord–this time PKC-gamma neurons, which lay adjacent to CR neurons at the border between the second and third layer of the dorsal horn–were responsible for animals feeling neuropathic-induced pain but not pain of inflammatory origin.
Lastly, researchers found that Cholecystokinin (CCK) neurons located deeper within the layers of the dorsal horn are important for both types of injuries.
“Now that we know more about how spinal circuitry of pain is organized, we can use gene therapy to shut it off,” said Seal. Her lab currently is working on developing ways to target neurons in the spinal cord using viral gene therapy and chemogenetics in patients experiencing mechanical allodynia.
“A lot of work has been done to understand how sensory neurons transmit pain signals, but we didn’t know much about what happens in the spinal cord,” she added. “Cracking that black box open in this unique way feels particularly exciting.”
In a manuscript published in the same issue of Neuron and co-authored by Seal, Graziana Gatto, Ph.D., and Martyn Goulding, Ph.D., both of The Salk Institute for Biological Sciences in California, use similar experimental approaches to describe the wiring of the motor behavioral responses to acute pain and touch sensation in the spinal cord.
Additional authors on this research include Cedric Peirs, Ph.D., Sean-Paul G. Williams, Xinyi Zhao, M.D., Cynthia M. Arokiaraj, David W. Ferreira, Ph.D., Myung-chul Noh, Ph.D., Kelly M. Smith, Ph.D., Priyabrata Halder, Ph.D., Kelly A. Corrigan, Jeremy Y. Gedeon, Suh Jin Lee, David Chi, M.D., and Sarah Ross, Ph.D., all of Pitt.
This research was funded by the Rita Allen Foundation, American Pain Association, American Diabetes Association, National Institutes of Health grants NS104964, NS096705 and AR063772, NS111643, NS073548, NS111791, David Scaife Family Charitable Foundation Fellowships, and the China Scholarship Council Foundation.
E-mail: [email protected]
To read this release online or share it, visit
[when embargo lifts].
About the University of Pittsburgh School of Medicine
As one of the nation’s leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region’s economy. For more information about the School of Medicine, see http://www.